<?xml version="1.0" encoding="UTF-8"?>
<p>Ang1-7 is already in the spotlight of scientific research given its beneficial effects in preventing the development of metabolic disorders and obesity (
 <xref rid="B83" ref-type="bibr">83</xref>). We believe that our literature review highlights the beneficial effects of Ang1-7 on meta-inflammation in preexisting obesity and its potential involvement in inflammatory response and viral clearance, notably against SARS-CoV-2. Modulation of the renin-angiotensin system has been mentioned by others to explain the severity of COVID-19. A recent study found a lower mortality and intubation risk during COVID-19 among elderly patients treated with nifedipine or amlodipine (
 <xref rid="B84" ref-type="bibr">84</xref>), although the study sample was small and most of the accessible data do not suggest a strong connection (
 <xref rid="B85" ref-type="bibr">85</xref>, 
 <xref rid="B86" ref-type="bibr">86</xref>). However, these drugs interfere with AT1R and not with the genuine production of Ang1-7.
</p>
